维普中文期刊产品整合服务
72篇 您的检索式:作者名="PATRIARCA F"
    题名 作者 年代 出处 被引量
1Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation 显示文摘Patriarca F Prosdocimo S Tomadini V 2005Haematology2005,90,2:1
2Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation 显示文摘Patriarca F Gaidano G Capello D 2000Haematologica2000,85,9:1
3Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation:incidence,predictors and outcome显示文摘Skert C Patriarca F Sperotto A 2006Haematologica2006,91,2:1
4A comparison of allografting with au- tografting for newly diagnosed myeloma显示文摘Bruno B Rotta M Patriarca F 2007N Engl J Med2007,356,11:1
5Bortezomib with thalidomide plus dexamethasone compared with thalido- mide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem- cell transplantation in newly diagnosed multiple myelo- ma:a randomised phase 3 study 显示文摘Cavo M Tacchetti P Patriarca F 2010Lancet2010,376,9758:1
6Incidence, outcome, and risk factors of /ate-onset noninfectious pulmonary,- complications after unrelated donor stem cell transplanta- tion显示文摘Patriarca F Skert C Sperotto A 2004Bone Marrow Transplant2004,33,7:1
7Clinical prese-ntation,outcome and risk factors of late-onset noninfectious pulmonary complications after allogeneic stem cell transplant-ation显示文摘Patriarca F Poletti V Costabel U 2009Curr Stem Cell Res Ther2009,4,2:1
8Pretransplantation fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation显示文摘Dodero A Crocchiolo R Patriarca F 2010Cancer2010,116,21:1
9A comparison of allografting with antografting in myeloma显示文摘Bruno B Rotta M Patriarca F 2007N Engl J Med2007,356,:1
10Clinical presentation, outcome and risk factors of late - onset non - infectious pulmonary complications ',ffter allogeneic stem cell transplantation 显示文摘Patriarca F Poletti V Costabel U 2009Curt Stem Cell Res Ther2009,4,2:1
11Incidence,outcome,and risk factors of late-onset noninfectious pulmonary complicat-ions after unrelated donor stem cell transplantation显示文摘Patriarca F Skert C Sperotto A 2004Bone Marrow Transplant2004,33,7:1
12Superior complete response rate and progression-free survival after autologous transplantation with up-front velcade-thalidomide-dexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma显示文摘Cavo M Tacchetti P Patriarca F 2008Blood2008,112,11:1
13Al ogeneic stem cel transplantation in multiple myeloma relapsed after autograft:a multicenter retrospective study based on donor availability显示文摘Patriarca F Einsele H Spina F 0,,04:1
14A phase III study of double autotransplantation incorporating bortezomib-thalidomide-dexamethasone (VTD) or thalidomide dexamethasone (TD) for multiple myeloma:superior clinical outcomes with VTD compared to TD显示文摘Cavo M Tacchetti P Patriarca F 2009{H}Blood2009,,22:1
15Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation显示文摘Montefusco V Spina F Patriarca F 2013Biol Blood Marrow Transplant2013,19,:1
16Prognostic relevance of ^18-F FDG PET / CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation 显示文摘Zamagni E Patriarca F Nanni C 2011Blood2011,118,23:1
17A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the as- sessment of bone disease in newly diagnosed multiple myeloma 显示文摘Zamagni E Nanni C Patriarca F 2007Haematologica2007,92,1:1
18Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab显示文摘Patriarca F Medeot M Isola M 2013Transpl Infect Dis2013,15,3:1
19A comparison of al ografting with autografting for newly diagnosed myeloma显示文摘Bruno B Rotta M Patriarca F 0,,11:1
20Efficacy of bortezomib therapy for extra - medullary relapse of myeloma after autologous and non - myeloablative allogeneic transplantation 显示文摘Patriarca F Prosdocimo S Tomadini V 2005Haematologiea2005,90,2:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费